We are live on ! Find out more
PMEF

Point72 Middle East FZE Portfolio holdings

AUM $3.38B
1-Year Est. Return 14.09%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+14.09%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.6B
AUM Growth
+$670M
Cap. Flow
+$559M
Cap. Flow %
15.51%
Top 10 Hldgs %
16.11%
Holding
2,193
New
624
Increased
517
Reduced
333
Closed
712

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$124M
2
CI icon
Cigna
CI
+$26.3M
3
LOW icon
Lowe's Companies
LOW
+$26M
4
V icon
Visa
V
+$24.5M
5
UNH icon
UnitedHealth
UNH
+$23.8M

Sector Composition

Rank Sector Weight
1 Technology 8.68%
2 Healthcare 7.32%
3 Consumer Discretionary 7.26%
4 Financials 6.68%
5 Industrials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPWK icon
2076
Upwork
UPWK
$1.21B
-6,806
Closed -$77K
URI icon
2077
United Rentals
URI
$70.8B
-277
Closed -$103K
USB icon
2078
US Bancorp
USB
$100B
-196,378
Closed -$6.35M
AD
2079
Array Digital Infrastructure
AD
$3.03B
-1,496
Closed -$31K
UTZ icon
2080
Utz Brands
UTZ
$1.25B
-1,250
Closed -$20.6K
V icon
2081
Visa
V
$675B
-106,874
Closed -$24.5M
VALE icon
2082
Vale
VALE
$63.4B
-117,418
Closed -$1.66M
VALE icon
2083
PUT
Vale
VALE
$63.4B
-38,200
Closed -$603K
VATE icon
2084
INNOVATE Corp
VATE
$97.3M
-683
Closed -$20.3K
VCEL icon
2085
Vericel Corp
VCEL
$2.25B
-3,279
Closed -$96.1K
VERV
2086
DELISTED
Verve Therapeutics
VERV
-16,498
Closed -$238K
VICR icon
2087
Vicor
VICR
$9.63B
-2,755
Closed -$129K
VKTX icon
2088
Viking Therapeutics
VKTX
$4.02B
-280
Closed -$4.67K
VLO icon
2089
Valero Energy
VLO
$90.7B
-1,236
Closed -$144K
VMC icon
2090
CALL
Vulcan Materials
VMC
$37B
-3,200
Closed -$549K
VMC icon
2091
Vulcan Materials
VMC
$37B
-21,365
Closed -$3.67M
VMD icon
2092
Viemed Healthcare
VMD
$355M
-4,941
Closed -$47.7K
VNRX icon
2093
VolitionRx Ltd
VNRX
$9.24M
-9
Closed -$353
VRCA icon
2094
Verrica Pharmaceuticals
VRCA
$88M
-320
Closed -$20.8K
VRNS icon
2095
Varonis Systems
VRNS
$4.87B
-16,976
Closed -$442K
VRTX icon
2096
Vertex Pharmaceuticals
VRTX
$133B
-16
Closed -$5.39K
VTOL icon
2097
Bristow Group
VTOL
$1.38B
-2,387
Closed -$53.5K
VTRS icon
2098
Viatris
VTRS
$18.7B
-7,567
Closed -$72.8K
VZ icon
2099
Verizon
VZ
$195B
-124,581
Closed -$4.61M
WAT icon
2100
Waters Corp
WAT
$40.4B
-7,407
Closed -$2.29M

Similar funds

Point72 Middle East FZE's Q2 2023 Portfolio in Review

As of Q2 2023, Point72 Middle East FZE held 2,193 positions worth $3.6B, up 23% from $2.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Point72 Middle East FZE deployed $559M of net new capital in Q2 2023, opening 624 new positions and adding to 517 existing holdings. Its largest new stake was AbbVie: 129,855 shares worth $17.5M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Honeywell, an estimated $21.6M trimmed.

  • Point72 Middle East FZE's largest Q2 2023 buy was AbbVie: 129,855 shares worth $17.5M.
  • Point72 Middle East FZE added most to iShares Russell 2000 ETF in Q2 2023, an estimated $50.1M increase.
  • Point72 Middle East FZE's biggest Q2 2023 reduction was Honeywell, cutting an estimated $21.6M.
  • Point72 Middle East FZE fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $124M.
  • Point72 Middle East FZE's ten largest holdings make up 16% of its $3.6B portfolio in Q2 2023.
  • Point72 Middle East FZE opened 624 new positions and closed 712 in Q2 2023.
  • Point72 Middle East FZE's portfolio value rose 23% quarter-over-quarter to $3.6B.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.